High materiality7/10
LB Pharmaceuticals price target raised to $53 from $40 at Stifel
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
LBRX target raised to $53 from $40 by Stifel Nicolaus; posted price $45.38.
- Stifel raises LBRX target to $53 from $40; price $45.38.
Key facts
- 01
Target: $53
- 02
Posted price: $45.38
- 03
Analyst firm: Stifel Nicolaus
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.